Superior vena cava syndrome. Experience with endovascular stents and surgical therapy

N. Schindler, R. L. Vogelzang*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

72 Scopus citations


Superior vena cava (SVC) syndrome is a serious complication of benign and malignant diseases. Benign causes may be increasing because of the increased use of central venous cannulation. Modern surgical therapy is durable with a few complications. Traditional treatment for SVC obstruction from malignant causes has consisted of anticoagulation, radiation, chemotherapy, and occasionally surgery. Endovascular techniques present a new treatment option for these patients, and uses a combination of thrombolysis, angioplasty, and intravascular stents. Short-term results are excellent with relatively rapid patient recovery. Further research is needed to elucidate the long-term results of endovascular treatment and to find its role in benign and malignant disease.

Original languageEnglish (US)
Pages (from-to)683-694
Number of pages12
JournalSurgical Clinics of North America
Issue number3
StatePublished - 1999

ASJC Scopus subject areas

  • Surgery

Fingerprint Dive into the research topics of 'Superior vena cava syndrome. Experience with endovascular stents and surgical therapy'. Together they form a unique fingerprint.

Cite this